Canadian Allergy & Immunology Today
https://canadianallergyandimmunologytoday.com/
Catalytic Healthen-USCanadian Allergy & Immunology Today2563-7711Updates on the Treatment and Management of Urticaria in 2025
https://canadianallergyandimmunologytoday.com/article/view/5-2-Robles-Velasco_et_al
<p class="p1">Chronic spontaneous urticaria (CSU) is increasingly recognized as a complex immune-mediated disorder, driven by interactions among T cells, mast cells, and inflammatory mediators. This paper summarizes the latest advances in urticaria treatment and management, incorporating new targeted therapies and evidence-based clinical guidelines.</p>Karla Robles-VelascoVeronica Ferris PasquiniPatryck PontesHermenio Lima
Copyright (c) 2025 Canadian Allergy & Immunology Today
2025-11-042025-11-045–165–1610.58931/cait.2025.5282Venom Immunotherapy in 2025: Practical Insights for Community Allergists
https://canadianallergyandimmunologytoday.com/article/view/5-2-Dhir
<p class="p1">Hymenoptera venom allergy (HVA), caused by stings from bees, wasps, hornets, and yellow jackets, is one of the most common identifiable causes of anaphylaxis in adults. While local reactions are common, systemic responses can be fatal. Venom immunotherapy (VIT) offers long-term protection and is often curative. Introduced in the 1920s, VIT remains the only disease-modifying treatment for HVA.</p>Arun Dhir
Copyright (c) 2025 Canadian Allergy & Immunology Today
2025-11-042025-11-0417–2217–2210.58931/cait.2025.5283Pearls from the European Academy of Allergy and Clinical Immunology (EAACI) Congress, 2025
https://canadianallergyandimmunologytoday.com/article/view/5-2-Mukherjee
<p class="p1">The European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025, held in Glasgow, Scotland, United Kingdom from June 13 to 16, centred on the overarching theme of “Breaking boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future.” Indeed, this year’s theme emphasized the intersection of environmental health and allergic diseases. The vibrant congress featured several presentations on immunological diseases in both adult and pediatric populations, along with breakthroughs in clinical and translational domains. Key topics included asthma, allergy, chronic spontaneous urticaria, and current global challenges such as pollution and climate change. This report highlights several key studies, organized under three main themes: pediatric studies, biologics in combined airways disease, and biomarkers.</p>Manali Mukherjee
Copyright (c) 2025 Canadian Allergy & Immunology Today
2025-11-042025-11-0423–2923–2910.58931/cait.2025.5284